The United States will open for fully vaccinated travellers against coronavirus in November from 33 countries including China, India, Brazil and most of Europe. The White House later clarified that the final decision on what vaccines would be accepted is up to the US Centers for Disease Control and Prevention (CDC). The apex medical body of the country has said that it considers a person "fully vaccinated" against Covid-19 if they have received any FDA-authorised jab or any vaccine that has been authorised by the World Health Organization (WHO). Foreign nationals will need to present proof of vaccination before travel. They will not be required to quarantine on arrival. Covaxin, developed by Bharat Biotech does not qualify as it has neither been approved by the WHO nor the US FDA. As per a PTI report, WHO approval for Covaxin is likely to come this month.